This page lists the SEC filings reported by HHLR ADVISORS, LTD..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | TAL Education Group | 8,927,663 | 6.2% | EDGAR |
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Yatsen Holding Ltd | 342,284,052 | 20.1% | EDGAR |
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Apellis Pharmaceuticals, Inc. | 5,028,289 | 6.6% | EDGAR |
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Gossamer Bio, Inc. | 7,420,974 | 9.8% | EDGAR |
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | iQIYI, Inc. | 270,539,345 | 10.3% | EDGAR |
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Bilibili Inc. | 5,067,027 | 2.1% | EDGAR |
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Viela Bio, Inc. | 2,382,414 | 4.3% | EDGAR |
| SC 13G/A | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Kiniksa Pharmaceuticals, Ltd. | 2,920,023 | 9.2% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Futu Holdings Ltd | 1,200,000 | 0.2% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | KE Holdings Inc. | 176,255,685 | 6.6% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Beam Therapeutics Inc. | 2,966,403 | 5.1% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Root, Inc. | 4,468,917 | 7.3% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | MINISO Group Holding Ltd | 60,401,152 | 6.8% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | LEAP THERAPEUTICS, INC. | 3,716,240 | 6.2% | EDGAR |
| SC 13G | 2021-02-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Aligos Therapeutics, Inc. | 2,165,064 | 5.7% | EDGAR |
| SC 13D/A | 2020-12-21 | HILLHOUSE CAPITAL ADVISORS, LTD. | I-Mab | 22,492,602 | 13.7% | EDGAR |
| SC 13G | 2020-12-16 | HILLHOUSE CAPITAL ADVISORS, LTD. | Yatsen Holding Ltd | 350,744,474 | 20.6% | EDGAR |
| SC 13D/A | 2020-11-23 | HILLHOUSE CAPITAL ADVISORS, LTD. | China Biologic Products Holdings, Inc. | 2,962,076 | 7.6% | EDGAR |
| SC 13D/A | 2020-10-28 | HILLHOUSE CAPITAL ADVISORS, LTD. | China Biologic Products Holdings, Inc. | 2,962,076 | 7.7% | EDGAR |
| SC 13D/A | 2020-09-18 | HILLHOUSE CAPITAL ADVISORS, LTD. | China Biologic Products Holdings, Inc. | 2,962,076 | 7.7% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.